| 000 | 01973naaaa2200301uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/45625 | ||
| 005 | 20220220095135.0 | ||
| 020 | _aintechopen.69906 | ||
| 020 | _a9781789230826 | ||
| 020 | _a9781789230833 | ||
| 024 | 7 |
_a10.5772/intechopen.69906 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aAndrew T.C. Tsin _4auth |
|
| 700 | 1 |
_aJeffery G. Grigsby _4auth |
|
| 245 | 1 | 0 | _aEarly Events in Diabetic Retinopathy and Intervention Strategies |
| 260 |
_bIntechOpen _c2018 |
||
| 300 | _a1 electronic resource (102 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aThe development of diabetic retinopathy is a long slow process affected by hyperglycemia, hypertension, lipid levels and genetics. It is expected that in 20 years' duration nearly all those with diabetes will exhibit diabetic retinopathy. In some patients, it will progress to blindness. While the number of individuals with diabetes increases, our current treatments are only effective at advanced levels of disease. Further, our screening methods to detect those needing treatment are currently not optimal. Early Events in Diabetic Retinopathy and Intervention Strategies covers topics addressing imaging processes currently available in the development of diabetic retinopathy screening. Potential biomarkers, that may be used to identify those at risk and illuminate the new pathways which lead to diabetic retinopathy, are expounded. | ||
| 540 |
_aAll rights reserved _4http://oapen.org/content/about-rights |
||
| 546 | _aEnglish | ||
| 653 | _aMedicine | ||
| 653 | _aOphthalmology | ||
| 653 | _aHealth Sciences | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://www.intechopen.com/books/early-events-in-diabetic-retinopathy-and-intervention-strategies _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/45625 _70 _zDOAB: description of the publication |
| 999 |
_c79693 _d79693 |
||